James Topper

James Topper

Director/Board Member at ALPINE IMMUNE SCIENCES, INC.

Net worth: 3 M $ as of 2024-02-28

62 year
Health Technology
Finance
Consumer Services

Profile

Jamie is a Managing Partner of Frazier Healthcare Partners' Life Sciences team.
He joined Frazier in 2003 and opened Frazier's Menlo Park office in the same year.
Throughout his 16 years as a Managing Partner, Jamie has invested across over 35 companies encompassing a broad spectrum of Life Science and Biopharmaceutical companies.
Jamie has led many of Frazier's successful life sciences investments, including Acerta Pharma BV (sold to AstraZeneca), Amunix Pharmaceuticals (sold to Sanofi), Calistoga Pharmaceuticals (co-founder, sold to Gilead Sciences), Mavupharma (sold to AbbVie), Rempex (sold to The Medicines Company), Incline (co-founder, sold to The Medicines Company), Ainara (sold to Lilly), Portola (co-founder, NASDAQ: PTLA), CoTherix (sold to Actelion), and Threshold (NASDAQ: THLD).
He currently represents Frazier on the boards of Alpine Immune Sciences (NASDAQ: ALPN), AnaptysBio (NASDAQ: ANAB), Lassen Therapeutics, NewAmsterdam Pharma (NASDAQ: NAMS), Phathom Pharmaceuticals (NASDAQ: PHAT), and Seraxis.
In addition, Jamie is a board observer for Alcresta Therapeutics.
He previously served as Chairman and Chief Executive Officer of Frazier- sponsored SPAC Frazier Lifesciences Acquisition Corporation.
Prior to joining Frazier, Jamie was the head of cardiovascular R&D at Millennium Pharmaceuticals and ran Millennium San Francisco (formerly COR Therapeutics).
Before the merger of COR and Millennium, he served as the Vice President of Biology at COR and was responsible for all research activities.
He served on the medical school faculties at Stanford and Harvard Medical School prior to joining COR.
Jamie received his M.D.
and Ph.D.
in Biophysics from Stanford and holds a B.S.
from the University of Michigan.
He did his postgraduate training in Internal Medicine and Cardiovascular Disease at the Brigham and Women's Hospital in Boston.
He has authored over 50 publications and was the recipient of a Howard Hughes Scholars Award while on the faculty at Stanford.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-03-23 80,812 ( 0.30% ) 2 M $ 2024-02-28
2024-03-03 30,647 ( 0.03% ) 315 051 $ 2024-02-28
2023-05-24 21,596 ( 0.04% ) 231 077 $ 2024-02-28
2023-12-30 61,307 ( 0.06% ) 171 660 $ 2024-02-28
2023-11-19 0 ( -.--% ) - $ 2024-02-28

James Topper active positions

CompaniesPositionStart
ALPINE IMMUNE SCIENCES, INC. Director/Board Member 2016-05-31
PHATHOM PHARMACEUTICALS, INC. Director/Board Member 2022-09-21
FRAZIER LIFESCIENCES ACQUISITION CORPORATION Director/Board Member 2022-10-31
Private Equity Investor 2002-12-31
Director/Board Member -
Director/Board Member 2018-09-30
Director/Board Member -
Director/Board Member -
Director/Board Member -
░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
All active positions of James Topper

Former positions of James Topper

CompaniesPositionEnd
░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of James Topper's experience

Training of James Topper

University of Michigan Undergraduate Degree
Stanford University School of Medicine Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of James Topper's experience

Connections

100 +

1st degree connections

49

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies8
AMICUS THERAPEUTICS, INC.

Health Technology

ANAPTYSBIO, INC.

Health Technology

SILENCE THERAPEUTICS PLC

Commercial Services

APTINYX

Health Technology

ALPINE IMMUNE SCIENCES, INC.

Health Technology

PHATHOM PHARMACEUTICALS, INC.

Health Technology

FRAZIER LIFESCIENCES ACQUISITION CORPORATION

Health Technology

ALLENA PHARMACEUTICALS, INC.

Health Technology

Private companies38

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

FHM Life Sciences VIII LLC

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Finance

Commercial Services

Technology Services

Health Technology

See company connections
  1. Stock
  2. Insiders
  3. James Topper